论文部分内容阅读
目的探讨胺碘酮对急性心衰合并快速房颤的临床疗效。方法从2012年3月~2014年12月在本院治疗的急性心衰合并快速房颤患者中选取72例,将其随机分为两组,对照组与观察组各36例。对照组给予常规抗心衰治疗,观察组在此基础上应用胺碘酮注射液治疗,对比两组临床疗效。结果和对照组相比,观察组在心率控制、心功能改善与复律方面均有明显好转(P<0.05);对比死亡率,观察组明显低于对照组(P<0.05)。结论对于急性心衰合并快速房颤患者来说,应在常规抗心衰治疗的基础上运用胺碘酮注射液治疗,可取得不错的疗效,还能改善心功能。
Objective To investigate the clinical effect of amiodarone on acute atrial fibrillation combined with rapid atrial fibrillation. Methods From March 2012 to December 2014, 72 patients with acute AF complicated by AF in our hospital were randomly divided into two groups, 36 in each of control group and observation group. The control group was given conventional anti-heart failure treatment. The observation group was treated with amiodarone injection on the basis of the above results, and the clinical efficacy was compared between the two groups. Results Compared with the control group, the observation group had a significant improvement in heart rate control, cardiac function improvement and cardioversion (P <0.05). The comparative mortality rate in the observation group was significantly lower than that in the control group (P <0.05). Conclusion For patients with acute heart failure complicated by rapid AF, amiodarone injection should be used on the basis of routine anti-heart failure treatment, which can achieve good therapeutic effect and improve cardiac function.